Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO2 | P16083 | 1/20 | 0.57 |
| ▸ | ESR1 | P03372 | 7/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6786351 | 1.00 | NQO2 (0.57) | NQO2ESR1LMNAMAPTMEN1 | |
| SCHEMBL9682602 | 0.79 | CES2 (0.46) | LMNAMAPTCYP1A2CYP3A4ALOX15 | |
| SCHEMBL19071788 | 0.79 | CES2 (0.46) | LMNAMAPTCYP1A2CYP3A4ALOX15 | |
| SCHEMBL9682609 | 0.79 | CES2 (0.46) | LMNAMAPTCYP1A2CYP3A4ALOX15 | |
| SCHEMBL27986961 | 0.79 | CES2 (0.46) | NQO2LMNAMAPTMEN1CYP1A2 | |
| SCHEMBL9865404 | 0.79 | TSHR (0.55) | TP53ALOX15KMT2ACA1CA2 | |
| SCHEMBL2805466 | 0.79 | POLB (0.53) | NQO2ESR1LMNAMAPTMEN1 | |
| SCHEMBL2805463 | 0.79 | POLB (0.53) | NQO2ESR1LMNAMAPTMEN1 | |
| SCHEMBL262669 | 0.78 | ALDH1A1 (0.52) | LMNAMAPTMEN1TP53CYP3A4 | |
| SCHEMBL19792666 | 0.78 | ALDH1A1 (0.52) | LMNAMAPTMEN1TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115120722-A | Use of SP/KLF transcription factor inhibitors | 天津医科大学 | 2022-09-30 | — | — | CN | claimed |
| CN-115120722-B | Use of SP/KLF transcription factor inhibitors | 天津医科大学 | 2024-02-09 | — | — | CN | disclosed |
| CN-111759827-B | A pharmaceutical composition for preventing or treating arthritis or inflammatory diseases | 忠北大学校产学协力团 | 2023-02-07 | — | — | CN | disclosed |
| CN-115120722-A | Use of SP/KLF transcription factor inhibitors | 天津医科大学 | 2022-09-30 | — | — | CN | disclosed |
| CN-112239401-B | Method for efficiently synthesizing 1, 3-di (4-hydroxyphenyl) -2-propylene-1-ketone | 南昌大学 | 2021-12-14 | — | — | CN | disclosed |
| CN-112239401-B | Method for efficiently synthesizing 1, 3-di (4-hydroxyphenyl) -2-propylene-1-ketone | 南昌大学 | 2021-12-14 | — | — | CN | disclosed |
| CN-107438433-B | Pharmaceutical composition for preventing and treating arthritis or inflammatory diseases containing 2-methoxy-4- (3- (4-methoxyphenyl) prop-1-en-1-yl) phenol as an active ingredient | 忠北大学校产学协力团 | 2021-06-25 | — | — | CN | disclosed |
| CN-112239401-A | Method for efficiently synthesizing 1, 3-di (4-hydroxyphenyl) -2-propylene-1-ketone | 南昌大学 | 2021-01-19 | — | — | CN | disclosed |
| CN-112239401-A | Method for efficiently synthesizing 1, 3-di (4-hydroxyphenyl) -2-propylene-1-ketone | 南昌大学 | 2021-01-19 | — | — | CN | disclosed |
| CN-107090414-B | Pesticidal flavobacterium strains | 马罗内生物创新公司 | 2020-12-04 | — | — | CN | disclosed |
| CN-111759827-A | A pharmaceutical composition for preventing or treating arthritis or inflammatory diseases | 忠北大学校产学协力团 | 2020-10-13 | — | — | CN | disclosed |
| CN-105963284-A | Medical application of bavachalcone and analogue thereof | 上海中医药大学 | 2016-09-28 | — | — | CN | disclosed |
| US-6803367-B2 | ANTICANCER AGENTS; SYNERGISTIC MIXTURES | TAKARA SHUZO CO., LTD. (JP) | 2004-10-12 | — | — | US | disclosed |
| US-20030065014-A1 | Substance for inducing apoptosis | TAKARA BIO INC. (JP) | 2003-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030065014-A1 | Substance for inducing apoptosis | BAX, BCL2, BAD | NQO2 2200/4885ESR1 2678/4885LMNA 1030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.